Clinical trials: Survival , Tumor
the Time to Start Postoperative Chemotherapy
Factors Affecting the Time to Start Postoperative Chemotherapy in Colorectal Cancer
Colorectal cancers are common tumors and have undergone a great change in the last 20 years in terms of treatment principles. Significantly improved results in local recurrence and overall survival have begun to be obtained with…
- Trial name
- NCT04885283
- Where
- Turkey (Türkiye)
- Volunteers
- 800 people
- Sponsor
- Inonu University
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
The purpose of the study is to evaluate the safety and tolerability of pepinemab in combination with pembrolizumab as first-line treatment and determine a recommended Phase 2 dose (RP2D) in patients with recurrent or metastatic…
- Trial name
- KEYNOTE-B84 (NCT04815720)
- Testing
- pepinemab + pembrolizumab
- Where
- 15 sites in United States
- Volunteers
- 49 people
- Sponsor
- Vaccinex Inc.
Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety
Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial
Gastric cancer is the one of the leading cause of cancer death in the worldwide. Gastric cancer originates from the most superficial mucosal epithelial cells of the stomach wall, which can occur in various parts of the stomach…
- Trial name
- NCT03531931
- Testing
- Apatinib/Capecitatine
- Where
- China
- Volunteers
- 20 people
- Sponsor
- The First Affiliated Hospital of Xiamen University
Non Small Cell Lung Cancer, Survival
The Effect Of Aspirin On Survival in Lung Cancer
Lung cancer is the most common cancer in the western world. Only 10 to 15 % of patients diagnosed with lung cancer are suitable for potentially curative surgical treatment. Despite surgery, recurrence of lung cancer still occurs.
- Conditions
- Non Small Cell Lung Cancer, Survival, Aspirin
- Trial name
- NCT01058902
- Testing
- Aspirin 75 mg, no aspirin
- Where
- United Kingdom
- Sponsor
- Liverpool Heart and Chest Hospital NHS Foundation Trust
Gastric Cancer
Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
The purpose of the study is to evaluate the efficacy and safety of S-1 plus Oxaliplatin versus S-1 only as adjuvant chemotherapy after curative distal gastrectomy in patients with locally advanced gastric cancer.
- Trial name
- RESCUE-GC (NCT02867839)
- Testing
- Oxaliplatin plus S-1, S-1 only
- Where
- 15 sites in China
- Volunteers
- 29 people
- Sponsor
- Peking University Cancer Hospital & Institute
Melanoma, Squamous Cell Carcinoma of the Head and Neck
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
The purpose of this study is to test the safety of a course of injections containing Poly-ICLC in patients with advanced solid tumors that can be easily and safely reached with a needle.
- Conditions
- Melanoma, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Skin, Sarcoma of the Skin
- Trial name
- Hiltonol (NCT01984892)
- Testing
- Poly-ICLC
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Nina Bhardwaj
Fatigue
Evaluating Qigong as a Clinical Intervention for Cancer Survivors' Fatigue
This study compares Qigong movement-based meditation exercise with a healthy living exercise-wellness course. There are two primary goals of this research: 1.
- Trial name
- NCT02845492
- Testing
- Qigong, Complete Health Improvement Program (CHIP)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- The Miriam Hospital
Effects of Chemotherapy
Assessing Urinary Hormones in Female Cancer Survivors
Women of late to mid reproductive age may participate in a study using novel methodology to identify subtle changes in the reproductive endocrine axis via daily urine hormone analysis, which may have important implications for…
- Trial name
- AUHS (NCT03197532)
- Where
- United States
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
Malignant Pleural Mesothelioma
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
Liposomal doxorubicin consists on doxorubicin encapsulated in liposomes that are composed of phosphatidylcholine and cholesterol.
- Trial name
- NCT00886028
- Testing
- Liposomal doxorubicin, Cisplatin
- Where
- Mexico
- Volunteers
- 31 people
- Sponsor
- National Institute of Cancerología
Prostate Cancer
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors
Prostate cancer is a significant concern for Latiné men, with over 17,000 new cases annually. Decision-making for treatment is complex, especially due to barriers like low health literacy and cultural factors.
- Trial name
- NCT06435871
- Testing
- Expanded Prostate Cancer Index Composite and Decision Regret Scale
- Where
- United States
- Volunteers
- 55 people
- Sponsor
- Case Comprehensive Cancer Center
Meningioma, Meningioma Atypical
Predictive Factors for Survival in Aggressive Meningiomas
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma.
- Conditions
- Meningioma, Meningioma Atypical, Anaplastic Meningioma
- Trial name
- 23Men (NCT05793034)
- Testing
- Biological biomarker assessment
- Where
- Italy
- Volunteers
- 250 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Endometrial Neoplasms, Ovarian Neoplasms
Questionnaire Study for Gynecological Cancer Survivors
The purpose of this study is to evaluate the quality of life of long-term gynecologic cancer survivors.
- Conditions
- Endometrial Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms
- Trial name
- NCT00391664
- Testing
- Psychosocial
- Where
- 2 sites in United States
- Volunteers
- 1,000 people
- Sponsor
- U.S. Army Medical Research and Development Command
Metastatic Colorectal Cancer (mCRC)
A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)
The purpose of this study is to estimate the overall survival (OS) for US participants diagnosed with metastatic colorectal cancer (mCRC) by using Flatiron Health's individual patient level data.
- Trial name
- NCT05420909
- Where
- United States
- Volunteers
- 124 people
- Sponsor
- Bristol-Myers Squibb
Breast Cancer
Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer
The purpose of this study is to compare the rate of disease free survival (DFS) and distant disease free survival (DDFS) at 5 years in postmenopausal women with hormone receptor and lymph node positive breast cancer randomized…
- Trial name
- LEANEX (NCT00902954)
- Testing
- anastrozole, letrozole, exemestane
- Where
- China
- Volunteers
- 540 people
- Sponsor
- Fudan University
Breast Neoplasms, Survivorship
PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS
Breast cancer is the most frequently diagnosed cancer in women worldwide. An important portion of the breast cancer survivors will face chronic pain complaints.
- Conditions
- Breast Neoplasms, Survivorship, Pain, Chronic
- Trial name
- BCS-PI (NCT04730154)
- Testing
- Pain Neuroscience Education (PNE), Motivational Interviewing (MI), Biomedically-focused education
- Where
- 4 sites in Belgium
- Volunteers
- 156 people, healthy volunteers welcome
- Sponsor
- Universitair Ziekenhuis Brussel
Colon Cancer
ASPIRIN Trial Belgium
The purpose of this study is to determine whether acetylsalicylic acid is effective on the recurrence and survival of colon cancer patients.
- Trial name
- ASPIRIN (NCT03464305)
- Testing
- acetylsalicylic acid
- Where
- 29 sites in Belgium
- Volunteers
- 148 people
- Sponsor
- University Hospital, Antwerp
Lung Cancer
Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer
The goal of this clinical trial is to investigate if weekly symptom monitoring of patients with advanced lung cancer is associated with better survival and improved quality of life compared to standard follow-up.
- Trial name
- LUCA-S (NCT05621902)
- Testing
- Weekly symptom monitoring
- Volunteers
- 398 people
- Sponsor
- Mats Lambe
Non-Small Cell Carcinoma of Lung, Immunotherapy
Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy
This study is a retrospective, multicenter, observational cohort study in patients with advanced or locally advanced non-small cell lung cancer (NSCLC).
- Conditions
- Non-Small Cell Carcinoma of Lung, Immunotherapy, Advanced Non-Small Cell Lung Cancer
- Trial name
- NCT07668037
- Where
- China
- Volunteers
- 600 people
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fasting, Breast Cancer
Prolonged Nightly Fasting in Breast Cancer Survivors
This study is being done to examine whether fasting for 13 hours every night is feasible and if it can help breast cancer survivors lose weight and improve their health.
- Conditions
- Fasting, Breast Cancer, Survivorship, Breast Cancer Recurrent
- Trial name
- NCT04330339
- Testing
- Fasting
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Massachusetts General Hospital
Nasopharyngeal Carcinoma
Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma
The study is to evaluate the efficacy and safety of apatinib for adjuvant treatment of High-risk metastasis of nasopharyngeal carcinoma after IMRT with concurrent chemotherapy,including progression-free survival (PFS),evaluation…
- Trial name
- NCT03612219
- Testing
- Apatinib mesylate tablet, Intensity-modulated radiation therapy (IMRT), Cisplatin
- Where
- 6 sites in China
- Volunteers
- 240 people
- Sponsor
- Wei Jiang